Health Condition 1: null- BiRF-C is a product in research and development. The indication for the product when developed will be cervical dysplasia
Conditions
Interventions
None listed
Sponsors
India Medtronic Pvt Ltd
Medtronic Surgical Innovations
Eligibility
Inclusion criteria
Inclusion criteria: 20-60 years of age Patients undergoing total or radical hysterectomy due to non-malignant disease, during routine clinical care. The subject or her Legally Authorized Representative (LAR) has been informed about the nature of the study and the patient informed consent for study participation has been obtained prior to performing any study-related procedures from the subject or Legally Authorized Representative, as per applicable local requirements Study team able to test discarded excised tissues within 5 hours after hysterectomy
Exclusion criteria
Exclusion criteria: Malignancy/cancerous tissue in the uterus Not willing to consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ablation depthTimepoint: Within five hours of hysterectomy performed as per routine clinical care | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicableTimepoint: Not applicable | — |
Countries
India
Contacts
Public ContactVinay Rajan
Regional Clinical Indian Subcontinent
Outcome results
None listed